Takeda Pharmaceutical (TAK) shares outstanding

Shares outstanding · fiscal 2026
3.21B

Takeda Pharmaceutical (TAK) had 3.21B diluted shares on average in fiscal 2026 (the year ended March 31, 2026). That is 0.2% lower than the 3.21B of fiscal 2025. Figures as of 18 Nov 2026, 12:13 UTC, from Yahoo Finance.

Key facts

Shares outstanding, fiscal 2026
3.21B
Change on fiscal 2025
−0.2%
Highest on record
3.21Bfiscal 2025
Lowest on record
3.14Bfiscal 2023
Fiscal years on record
42023–2026

Figures as of . Statements from Yahoo Finance. Figures, not advice.

Takeda Pharmaceutical shares outstanding, in more detail

The market data feed counts 3.19B shares outstanding today.

Across the 4 fiscal years on record (2023–2026), the highest was 3.21B in fiscal 2025 and the lowest 3.14B in fiscal 2023.

History · 4 fiscal years

Shares outstanding by fiscal year

Takeda Pharmaceutical shares outstanding, year by year

Takeda Pharmaceutical (TAK) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
20263.21B 0.2% down
20253.21B 1.6% up
20243.16B 0.7% up
20233.14B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Takeda Pharmaceutical and comparable companies
CompanyShares outstandingFiscal year
Takeda Pharmaceutical TAK3.21B2026
Cencora COR195.21M2025
Boston Scientific BSX1.49B2025
Cardinal Health CAH237.00M2026
argenx ARGX66.03M2025
Edwards Lifesciences EW585.80M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TAK

Takeda Pharmaceutical, figure by figure

Takeda Pharmaceutical (TAK) overview: price, valuation and scorecardAll health care companies by market value

Takeda Pharmaceutical shares outstanding: questions and answers

How many shares does Takeda Pharmaceutical have?

Takeda Pharmaceutical (TAK) had 3.21B diluted shares on average in fiscal 2026 (the year ended March 31, 2026). That is 0.2% lower than the 3.21B of fiscal 2025. The market data feed counts 3.19B shares outstanding today.

What are the highest and lowest diluted share count figures on record for Takeda Pharmaceutical?

Across the 4 fiscal years on record (2023–2026), the highest was 3.21B in fiscal 2025 and the lowest 3.14B in fiscal 2023.

How is Takeda Pharmaceutical's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Takeda Pharmaceutical it is on record here for 4 fiscal years, 2023 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Takeda Pharmaceutical (TAK) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/TAK/shares-outstanding

Underlying data: Yahoo Finance.